Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 4 Oct 23 RW Registration withdrawal request
- 1 Aug 23 S-4/A Registration of securities issued in business combination transactions (amended)
- 29 Jun 23 S-4/A Registration of securities issued in business combination transactions (amended)
-
15 May 23 S-4 Registration of securities issued in business combination transactions
BIOSU similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the use in the joint proxy statement/prospectus constituting a part of this Registration Statement on Form S-4 of our report dated March 31, 2023, relating to the financial statements of Bioplus Acquisition Corp., which is contained in that joint proxy statement/ prospectus. We also consent to the reference to our Firm under the caption “Experts” in the joint proxy statement/prospectus.
/s/ WithumSmith+Brown, PC
New York, New York
May 12, 2023